A Phase I Study of Motexafin Gadolinium (Xcytrin NSC 695238) and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood.
Phase of Trial: Phase I
Latest Information Update: 15 Jan 2013
At a glance
- Drugs Motexafin gadolinium (Primary)
- Indications Glioma
- Focus Adverse reactions
- 17 Dec 2010 Planned end date added 1 Mar 2007 as reported by ClinicalTrials.gov.
- 16 Nov 2010 Status changed from completed to recruiting as reported by ClinicalTrials.gov.
- 06 Sep 2005 New trial record.